HIGHLIGHTS
- who: Enrico Berrino from the Department of Medical Sciences, University of Turin, Turin, Italy have published the paper: Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas, in the Journal: (JOURNAL)
- what: The authors aimed at characterizing HLBCs at the molecular level to assess whether they represent a distinct entity. The authors show that HER2-low breast carcinomas harbor a constellation of somatic mutations that shows significant differences compared to HER2-positive and HER2negative BCs. The study provides an overview of the landscape of potentially targetable genetic alterations for HER2-low . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.